12th Apr 2011 18:00
Notification of Transactions of Directors, Persons Discharging
Managerial Responsibility or Connected Persons
The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 12 April 2011 of an increase in their notional interests in Ordinary shares at a price of £12.22 per share and ADRs at a price of $39.96 per ADR following the notional re-investment of the dividend paid to shareholders on 7 April 2011.
Ordinary shares | ADRs | |
Mr A P Witty | 14,586.55 | |
Dr M M Slaoui | 3,232.51 | |
Mr S M Bicknell | 1,095.91 | |
Mr J M Clarke | 3,300.39 | |
Mrs D P Connelly | 2,284.17 | |
Mr M Dunoyer | 1,578.62 | |
Mr E J Gray | 2,376.38 | |
Mr S A Hussain | 3,264.99 | |
Mr W C Louv | 997.91 | |
Dr D Pulman | 1,589.94 | |
Mr D S Redfern | 1,324.87 | |
Mr J R Stéphenne | 1,967.86 | |
Ms C Thomas | 1,949.85 | |
Mr D E Troy | 2,071.71 | |
Dr P J T Vallance | 1,213.62 | |
Mrs V A Whyte | 100.64 |
The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rules 3.1.4R(1)(a).
V A Whyte
Company Secretary
12 April 2011
Related Shares:
Glaxosmithkline